Blue Trust’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$797 Sell
42
-5
-11% -$90 ﹤0.01% 2209
2026
Q2
$736 Hold
47
– – ﹤0.01% 2331
2026
Q1
$471 Hold
47
– – ﹤0.01% 2352
2025
Q4
$1.43K Hold
47
– – ﹤0.01% 2209
2025
Q3
$934 Hold
47
– – ﹤0.01% 2340
2025
Q2
$684 Buy
+47
New +$665 ﹤0.01% 2291

Other funds holding BBNX

Blue Trust's BBNX Position: Q3 2026 in Review

Blue Trust reduced its Beta Bionics (BBNX) stake by 11% in Q3 2026, selling an estimated $90 and leaving 42 shares worth $797. The position accounts for ﹤0.01% of the portfolio, ranked #2209.

Blue Trust first reported a position in BBNX in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.43K in Q4 2025. 106 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • Blue Trust held 42 shares of Beta Bionics worth $797 as of Q3 2026.
  • Blue Trust sold 5 Beta Bionics shares in Q3 2026, an estimated $90.
  • Beta Bionics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2209 holding.
  • Blue Trust first reported a position in Beta Bionics in Q2 2025 and has held it in 6 quarters since.
  • Blue Trust's Beta Bionics position peaked at $1.43K in Q4 2025.
  • 106 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.